Moderna is leveraging its mRNA platform to expand beyond COVID-19 vaccines into RSV and oncology therapeutics. Vertex Pharmaceuticals maintains market dominance in cystic fibrosis while successfully ...

Vertex faced downward price pressure from biotech sector weakness and technical selling.Core fundamentals remain supported by ...

The former general manager of Marblehead’s Warwick Theater is publicly accusing the movie house’s ownership group of failing to pay employees, movie studios and vendors despite bringing in more than ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® ...

Quince Therapeutics, Inc. announced that Leone Patterson, age 63, Ms. Patterson served as Executive Vice President, Chief Business Officer and Chief Financial Officer of Zymeworks, Inc. from September ...

For the final 10% of cystic fibrosis patients who cannot benefit from breakthrough drugs, Emily's Entourage is funding ...

Previously disclosed post hoc PreciSION CF analyses of SION-719 support advancement of SION-451 + SION-2222 into the AscenSION CF Phase 2a ...

"Epicore and MECFA partner on wearable cystic fibrosis test" was originally created and published by Medical Device Network, a GlobalData owned brand.

Epicore Biosystems, a leader in wearable biosensor platforms for continuous, non-invasive health monitoring, today announced ...

For seven years, a renowned British hospital has grappled with a serious bacterial outbreak in its water supply that, ...

Vertex Pharmaceuticals VRTX-- (VRTX) shares dipped 0.40% on October 2, 2026, but led the market with $0.47B in trading volume ...